S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
America's Worst Nightmare: A Major Financial Crisis Looms (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
America's Worst Nightmare: A Major Financial Crisis Looms (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
How to Choose a Brokerage Account or Online Broker
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
America's Worst Nightmare: A Major Financial Crisis Looms (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
America's Worst Nightmare: A Major Financial Crisis Looms (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
How to Choose a Brokerage Account or Online Broker
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
America's Worst Nightmare: A Major Financial Crisis Looms (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
America's Worst Nightmare: A Major Financial Crisis Looms (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
How to Choose a Brokerage Account or Online Broker
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
America's Worst Nightmare: A Major Financial Crisis Looms (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
America's Worst Nightmare: A Major Financial Crisis Looms (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
How to Choose a Brokerage Account or Online Broker
NASDAQ:FLGT

Fulgent Genetics (FLGT) Stock Forecast, Price & News

$38.04
-1.59 (-4.01%)
(As of 06/9/2023 ET)
Compare
Today's Range
$37.92
$39.63
50-Day Range
$28.52
$40.70
52-Week Range
$28.27
$65.17
Volume
248,471 shs
Average Volume
232,754 shs
Market Capitalization
$1.13 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$42.33

Fulgent Genetics MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
11.3% Upside
$42.33 Price Target
Short Interest
Healthy
4.08% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.67
Upright™ Environmental Score
News Sentiment
0.32mentions of Fulgent Genetics in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$154,591 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.23) to ($1.80) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.23 out of 5 stars

Medical Sector

289th out of 987 stocks

Medical Laboratories Industry

7th out of 22 stocks


FLGT stock logo

About Fulgent Genetics (NASDAQ:FLGT) Stock

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.

Receive FLGT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fulgent Genetics and its competitors with MarketBeat's FREE daily newsletter.

FLGT Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Fulgent Genetics (NASDAQ:FLGT) PT Raised to $37.00
Fulgent Genetics Inc FLGT Stock Quote
See More Headlines

FLGT Price History

FLGT Company Calendar

Last Earnings
5/05/2023
Today
6/09/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FLGT
Employees
1,012
Year Founded
2011

Price Target and Rating

Average Stock Price Forecast
$42.33
High Stock Price Forecast
$45.00
Low Stock Price Forecast
$37.00
Forecasted Upside/Downside
+11.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$143.40 million
Pretax Margin
-10.69%

Debt

Sales & Book Value

Annual Sales
$618.97 million
Cash Flow
$6.26 per share
Book Value
$43.14 per share

Miscellaneous

Free Float
20,268,000
Market Cap
$1.13 billion
Optionable
Not Optionable
Beta
1.55

Social Links


Key Executives

  • Ming HsiehMing Hsieh
    Chairman & Chief Executive Officer
  • James Xie
    President & Chief Operating Officer
  • Paul H. KimPaul H. Kim
    Chief Financial Officer
  • Harry Gao
    Chief Scientific Officer & Laboratory Director
  • Lawrence M. Weiss
    Chief Medical Officer













FLGT Stock - Frequently Asked Questions

Should I buy or sell Fulgent Genetics stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FLGT shares.
View FLGT analyst ratings
or view top-rated stocks.

What is Fulgent Genetics' stock price forecast for 2023?

3 brokers have issued 1 year target prices for Fulgent Genetics' shares. Their FLGT share price forecasts range from $37.00 to $45.00. On average, they anticipate the company's stock price to reach $42.33 in the next twelve months. This suggests a possible upside of 11.3% from the stock's current price.
View analysts price targets for FLGT
or view top-rated stocks among Wall Street analysts.

How have FLGT shares performed in 2023?

Fulgent Genetics' stock was trading at $29.78 on January 1st, 2023. Since then, FLGT shares have increased by 27.7% and is now trading at $38.04.
View the best growth stocks for 2023 here
.

When is Fulgent Genetics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our FLGT earnings forecast
.

How were Fulgent Genetics' earnings last quarter?

Fulgent Genetics, Inc. (NASDAQ:FLGT) posted its quarterly earnings results on Friday, May, 5th. The company reported ($0.47) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.68) by $0.21. The company earned $66.17 million during the quarter, compared to analysts' expectations of $61.95 million. Fulgent Genetics had a negative trailing twelve-month return on equity of 1.05% and a negative net margin of 7.10%.

What guidance has Fulgent Genetics issued on next quarter's earnings?

Fulgent Genetics issued an update on its second quarter 2023 earnings guidance on Sunday, May, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $62.00 million-$62.00 million, compared to the consensus revenue estimate of $60.31 million.

What other stocks do shareholders of Fulgent Genetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Block (SQ), JD.com (JD), Marvell Technology (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT).

When did Fulgent Genetics IPO?

(FLGT) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,600,000 shares at $12.00-$14.00 per share. Credit Suisse and Piper Jaffray served as the underwriters for the IPO and Raymond James and BTIG were co-managers.

What is Fulgent Genetics' stock symbol?

Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."

Who are Fulgent Genetics' major shareholders?

Fulgent Genetics' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.28%), Dimensional Fund Advisors LP (2.87%), State Street Corp (2.69%), Geode Capital Management LLC (1.36%), JPMorgan Chase & Co. (1.15%) and American Century Companies Inc. (0.94%). Insiders that own company stock include Hanlin Gao, Jian Xie, John C Bolger, Paul Kim and X Cycle LP Tcv.
View institutional ownership trends
.

How do I buy shares of Fulgent Genetics?

Shares of FLGT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fulgent Genetics' stock price today?

One share of FLGT stock can currently be purchased for approximately $38.04.

How much money does Fulgent Genetics make?

Fulgent Genetics (NASDAQ:FLGT) has a market capitalization of $1.13 billion and generates $618.97 million in revenue each year. The company earns $143.40 million in net income (profit) each year or ($0.89) on an earnings per share basis.

How many employees does Fulgent Genetics have?

The company employs 1,012 workers across the globe.

Does Fulgent Genetics have any subsidiaries?
The following companies are subsidiares of Fulgent Genetics: CSI, Cytometry Specialists Inc., FF Gene Biotech, Fulgent Investment Development Limited, Fulgent Therapeutics LLC, and Inform Diagnostics.
Read More
How can I contact Fulgent Genetics?

Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. The official website for the company is www.fulgentgenetics.com. The company can be reached via phone at (626) 350-0537, via email at nborsje@blueshirtgroup.com, or via fax at 626-454-1667.

This page (NASDAQ:FLGT) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -